For instance, the ddPCR methodology can accomplish relatively quick evaluations, facilitating the timely administration of more intensive induction regimens in the distinctive KIT-D816-mutated t(8; 21) AML subset28. This evidence concerns the gene KIT and acute myeloid leukemia.